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Exposure to drug-associated cues to induce extinction is a useful strategy to contrast
cue-induced drug seeking. Norepinephrine (NE) transmission in medial prefrontal cortex
has a role in the acquisition and extinction of conditioned place preference induced by
amphetamine. We have reported recently that NE in prelimbic cortex delays extinction
of amphetamine-induced conditioned place preference (CPP). A potential involvement
of α1-adrenergic receptors in the extinction of appetitive conditioned response has
been also suggested, although their role in prelimbic cortex has not been yet fully
investigated. Here, we investigated the effects of the α1-adrenergic receptor antagonist
prazosin infusion in the prelimbic cortex of C57BL/6J mice on expression and extinction
of amphetamine-induced CPP. Acute prelimbic prazosin did not affect expression of
amphetamine-induced CPP on the day of infusion, while in subsequent days it produced
a clear-cut advance of extinction of preference for the compartment previously paired
with amphetamine (Conditioned stimulus, CS). Moreover, prazosin-treated mice that
had extinguished CS preference showed increased mRNA expression of brain-derived
neurotrophic factor (BDNF ) and post-synaptic density 95 (PSD-95) in the nucleus
accumbens shell or core, respectively, thus suggesting that prelimbic α1-adrenergic
receptor blockade triggers neural adaptations in subcortical areas that could contribute
to the extinction of cue-induced drug-seeking behavior. These results show that the
pharmacological blockade of α1-adrenergic receptors in prelimbic cortex by a single
infusion is able to induce extinction of amphetamine-induced CPP long before control
(vehicle) animals, an effect depending on contingent exposure to retrieval, since if
infused far from or after reactivation it did not affect preference. Moreover, they suggest
strongly that the behavioral effects depend on post-treatment neuroplasticity changes
in corticolimbic network, triggered by a possible “priming” effect of prazosin, and point
to a potential therapeutic power of the antagonist for maladaptive memories.
Keywords: α1-adrenergic receptors, extinction, prelimbic cortex, conditioned place preference, BDNF, PSD-95,
nucleus accumbens
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INTRODUCTION
Persistent memories about biologically relevant stimuli are
essentials for organism and species survival. However, in some
pathological conditions, highly salient memories are experienced
intrusively leading the individual to maladaptive behavior
(McGaugh, 2006; Sun et al., 2011; Puglisi-Allegra and Ventura,
2012). A typical example is drug addiction, a pathological
condition, in which environmental stimuli or discrete cue paired
with drug effects acquire the ability to induce intense drug
desire that leads to drug-seeking and drug-taking (Stewart et al.,
1984; Robinson and Berridge, 1993; Childress et al., 1999;
Everitt et al., 2001; Shalev et al., 2002). A method to reduce
this kind of responses is the extinction learning, a protocol
in which repeated cues or context re-exposure in absence of
the predicted event results in a decrease in magnitude and
frequency of conditioned response (CR) (Myers and Davis,
2004; Myers and Carlezon, 2012). This protocol, known as
exposure therapy, has been applied successfully in fear and
anxiety disorders treatment. However, its application on drug
addicts showed only limited success (Conklin and Tiffany,
2002). Therefore, a better understanding of neurobiological
mechanisms of extinction could be important to improve the
effectiveness of extinction-like protocols, and to envisage neural
targets to develop pharmacological therapy.
Modulation of the conditioned stimulus (CS) motivational
properties favors disengagement from drug-related cues. Thus,
therapy strategies aimed at reducing the motivational properties
of drug cues have been considered highly promising for successful
treatment of craving and relapse in addicts (Taylor et al., 2009). In
this framework, norepinephrine (NE) transmission in prefrontal
cortex acquires a pivotal role to favor disengagement from drug-
related cues.
Indeed, NE transmission in mPFC modulates central and
behavioral responses induced by relevant biological stimuli or
by neutral stimuli associated with them (Darracq et al., 1998;
Feenstra et al., 2001; Mingote et al., 2004; Ventura et al., 2005,
2007, 2008; Pascucci et al., 2007; Puglisi-Allegra and Ventura,
2012).
Drugs of abuse, natural reward and aversive stimuli promotes
NE increase in mPFC (Florin et al., 1994; Feenstra et al.,
2001; Mingote et al., 2004; Ventura et al., 2005, 2007; Pascucci
et al., 2007), leading to dopamine (DA) release in the NAc
that is critical for the attribution of motivational salience to
highly salient stimuli (Darracq et al., 1998; Ventura et al., 2003,
2005, 2007; Puglisi-Allegra and Ventura, 2012). Furthermore,
highly salient unconditioned stimulus (US) and conditioned
stimulus (CS) paired with them, increase NE levels in mPFC
proportionally to the salience of the US (Feenstra et al., 2001;
Mingote et al., 2004; Ventura et al., 2008). This indicates that
prefrontal NE transmission modulates motivational properties of
conditioned cues during exposure to them, strengthening them
and contributing to the maintenance of the CR. Consistent with
Abbreviations: α1-ARs, alpha1-adrenergic receptors; Amph, amphetamine
sulfate; BDNF, brain-derived neurotrophic factor; CPP, conditioned place
preference; IL, infralimbic mpFC; mpFC, medial prefrontal cortex; NAc, nucleus
accumbens; PL, prelimbic mpFC; PSD-95, post-synaptic density 95.
this view, we have recently reported that selective NE depletion
in pre-limbic cortex (PL), after acquisition of amphetamine CPP,
facilitates extinction of drug-associated memory (Latagliata et al.,
2016).
Alpha1-adrenergic receptors (α1-ARs) in mPFC have been
related to the modulation of motivational properties of salient
experiences. Indeed, α1-ARs that are preferentially engaged
during conditions of sustained prefrontal NE release (Ramos and
Arnsten, 2007) like highly salient experiences (Mingote et al.,
2004; Ventura et al., 2008), modulate both motivated behavior
and dopaminergic response in NAc induced by salient stimuli
(Blanc et al., 1994; Darracq et al., 1998; NicNiocaill and Gratton,
2007; Schmidt et al., 2017).
Thus, in the present work we investigated if α1-ARs in PL
cortex are involved in extinction of amphetamine-induced CPP
in mice.
Note that the selective α1-ARs antagonist prazosin is used in
clinical set for treatment of alcohol abuse and for post-traumatic
stress disorder (Raskind et al., 2003; Rasmussen et al., 2009).
Moreover, one of the pioneering studies by the Collège de France
team (Blanc et al., 1994) showed that infusion of prazosin in
the mpFC was able to control DA functioning in the NAc along
more than 1 day after treatment. This report encouraged us to
use prazosin in our experimental conditions in order to assess
the effects of a single treatment in animal exposed to extinction
training to possibly benefit from long-lasting pharmacological
effects of the compound.
Thus, in the present work we investigated the effects of
prazosin infusion in the PL of C57BL/6J mice on expression and
extinction of amphetamine-induced CPP, hypothesizing that a
single intra-PL prazosin infusion, before CPP trial (reactivation),
could reduce the motivational properties of the amphetamine
paired CS, weakening the persistence of amphetamine-induced
CPP.
In a first set of experiments, we observed that intra-PL
prazosin did not affect expression of amphetamine-induced
CPP the day of infusion, while in subsequent days, when
animals were drug free, it produced an early extinction in
comparison with vehicle infused group. This suggested that PL
α1-ARs blockade could have induced neuroplastic adaptations in
mesocorticolimbic areas of prefrontal-accumbal network known
to modulate incentive salience and extinction.
To assess this hypothesis, in a second set of experiments,
we assessed the transcriptional modulation of BDNF and
PSD-95 genes as markers of neuroplasticity and synaptic
maturation, respectively, in PL and infralimbic cortex (IL),
nucleus accumbens (NAc) shell and core, of prazosin treated mice
having extinguished preference for amphetamine CS.
MATERIALS AND METHODS
Animals
Male C57BL/6JIco (Charles River, Como, Italy) were purchased
at 6–7 weeks of age and housed four per cage on a 12-h light–
dark cycle (lights on between 07.00 a.m. and 07.00 p.m.) for
3 weeks. Two days before experiments, animals were individually
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housed. Each experimental group consisted of 7–10 animals. All
experiments were carried out in accordance with Italian national
law (DL 116/92 and DL 26/2014) on the use of animals and with
the European Communities Council Directives (86/609/EEC and
2010/63/UE), and approved by the ethics committee of the
Italian Ministry of Health (license/approval ID #: 10/2011-B and
42/2015-PR).
Drugs
D-Amphetamine sulfate (Amph) and Prazosin hydrochloride
(prazosin), were purchased from Sigma (Sigma Aldrich,
Milan, Italy). Fluorescently labeled prazosin, BODYPY FL, was
purchased by Thermo Fisher Scientific, Italy. Amph (2.5 mg/Kg),
was dissolved in saline (0.9% NaCl) and injected intraperitoneally
(i.p.) in a volume of 10 ml/kg. Zoletil 100, Virbac, Milan, Italy
(tiletamine HCl 50 mg/ml + zolazepam HCl 50 mg/ml) and
Rompun 20, Bayer S.p.A Milano, Italy (xylazine 20 mg/ml),
purchased commercially, were used as anesthetics. Prazosin and
BODYPY FL (1mg/ml) were dissolved in artificial CSF (in mM:
NaCl 140.0; KCl 4.0; CaCl2 1.2; MgCl2 1.0). Artificial CSF was
used as Vehicle. The doses of Amph and prazosin were selected
on the bases of previous studies (Darracq et al., 1998; Do-Monte
et al., 2013; Latagliata et al., 2016) and preliminary experiments.
Apparatus
A CPP apparatus (Cabib et al., 1996, 2000) was used for
behavioral experiments. The apparatus comprised two gray
Plexiglas chambers (15 cm × 15 cm × 20 cm) and a central alley
(15 cm × 5 cm × 20 cm). Two sliding doors (4 cm × 4 cm)
connected the alley to the chambers. In each chamber, two
triangular parallelepipeds (5 cm × 5 cm × 20 cm) made of black
Plexiglas and arranged in different patterns (always covering
the same surface of the chamber) were used as conditioned
stimuli. Behavioral data were registered and analyzed by a
fully automated video tracking system (“EthoVision”, Noldus
Information Technology, Wageningen, The Netherlands). The
acquired digital signal was processed by the software, to extract
the “time spent” [in second (s)] in the three chambers of the
apparatus.
Experimental Procedures
Experimental procedures are summarized in Figure 1.
Conditioned Place Preference
The training procedure was described previously (Cabib et al.,
1996). Briefly, on day 1 (pre-test), mice were free to explore
the entire apparatus for 20 min. On the following 8 days (con-
ditioning phase), mice were injected and confined daily for
40 min alternatively in one of the two chambers. One of the
patterns was consistently paired with a vehicle injection and the
other one with Amph injection. In order to balance the pairings
for half of the animals in each experimental group Amph (or
vehicle) was paired with one of the patterns and half of them
with the other one. Testing was carried out on day 10 in drug-free
state and lasted 20 min like the pre-test. Note that during pre-test,
mice randomly assigned to vehicle (n = 10) or prazosin (n = 10)
groups did not show preference (mean time spent ± SEM),
for the lateral chambers, thus showing that the apparatus was
unbiased in terms of preferences in untreated mice.
Surgery, Re-test and Infusions
The days following CPP test (days 11 and 12), animals were
subjected to surgical procedures. Mice, anesthetized with Zoletil
100 and Rompun 20, were mounted in a stereotaxic frame (David
Kopf Instruments, Tujunga, CA, United States) equipped with
a mouse adapter. An incision was performed along the midline
of the skull, then two holes were pierced in correspondence
of the PL cortex, coordinates: AP +2.8; ML ± 0.4 DV −0.4
from the bregma, according to the atlas of Paxinos and Franklin
(2001). Two steel cannulas were implanted (length: 7 mm; outer
diameter: 0.7 mm, internal diameter 0.35 mm), secured with
dental cement with the addition of epoxy glue.
One week after CPP test, the animals were subjected to a
further test (re-test) to check that surgeries did not impair place
preference. The day following CPP re-rest, bilateral injections
of prazosin or vehicle (0.6 µg/0.6 µl side) were performed into
PL through a stainless steel cannula (length 8.1 mm, 0.15 mm
outer diameter, UNIMED, Swiss), connected to a 10 µl Hamilton
syringe by a polyethylene tube and driven by a CMA/100 pump
(flow rate 0.6 µl/min). After the end of the infusion the cannula
was left in place for additional 30 s. Vehicle or prazosin pre-trial
group received the infusion 20 min before the CPP trial. Post trial
groups (vehicle or prazosin) received injection in PL 5 min after
CPP trial. Non-contingent groups received PL infusion of vehicle
or prazosin 5–6 h before the CPP trial.
Placement Assessment
To assess placement, drug dispersion, and tissue damage in the PL
a solution of a CSF containing the fluorescently labeled BODYPY
FL prazosin was infused as described before. Figure 2 shows
a representative image of the preparation used to determine
location of the cannula in the PL after infusion with CSF
(Figure 2A) or fluorescently labeled prazosin (Figure 2B).
Placements in PL were judged by methylene blue staining.
Brains were post-fixed in 4% paraformaldehyde, cut in serial
coronal slices according to Paxinos and Franklin (2001) and
processed for methylene blue staining. In order to reconstruct the
correct cannula placements 50-µm thick sections were examined
under a microscope to establish the location of the cannula.
In Figure 2 is represented the location of cannulas in the
two hemispheres. Data from animals not showing the proper
placement (n = 9 for all experiments) were discarded from the
final statistical analysis.
Extinction
The extinction procedure began the day after the re-test.
To investigate potential time-dependent differences in the
extinction, animals were exposed daily to CPP test (20 min)
(Orsini et al., 2008) (non-confined extinction). The extinction
of the CR was considered acquired after two consecutive days
showing non-significant preference for the drug-paired chamber
(Fricks-Gleason and Marshall, 2008; Latagliata et al., 2016).
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FIGURE 1 | Schematic time-line of the experimental procedures.
FIGURE 2 | (A) Representative image of infusion site in PL cortex; (B)
Location of bilateral cannula insertion to infuse fluorescently labeled prazosin
(BODYPY FL) in the prelimbic cortex, PL (see Materials and Methods). The
image is representative coronal photomicrographs of PL. The fluorescent
trace was used to evaluate the selectivity of the diffusion gradient. The
clearest part indicates the maximum spread of prazosin in the PL around the
cannula track. Scale bar = 200 µm.
Quantitative Real Time RT-PCR and
Gene Expression Analysis
After extinction of prazosin treated mice, the animals of the
four experimental groups were sacrificed, brains were removed
and stored in liquid nitrogen. Then, after brains were fixed
vertically on the freeze plate of a freezing microtome, punches
of both hemispheres were obtained from the brain slices (coronal
sections) no thicker than 300 µm. Stainless steel tubes of 1.0 mm
of inside diameter for PL and 0.5 mm for IL, NAc Core and NAc
Shell were used. The coordinates were measured according to the
Paxinos and Franklin (2001) atlas (coronal sections as mm from
bregma), as follows: PL two slices from 2.80 to 2.22; IL two slices
from 2.10 to 1.54; NAc Core and Shell three slices from 1.88 to
0.98. The punches were stored in liquid nitrogen until the day of
RNA extraction.
RNA was isolated from brain punches using Total RNA
purification Kit (Norgen Biotek, Thorold, ON, Canada)
according to the manufacturer protocol. RNA quantity was
determined by absorbance at 260 nm using a NanoDrop UV-
VIS spectrophotometer. Complementary DNA was obtained
using the High Capacity Reverse Transcription Kit (Applied
Biosystems, Branchburg, NJ, United States). cDNA templates
(8 ng) were amplified with quantitative PCR using the Taqman
technology in the 7900HT thermal cycler apparatus equipped
with the SDS software version 2.3 (Applied Biosystems) for data
collection. Taqman primer sets (Applied Biosystems) were used
to amplify mouse total BDNF (Mm04230607_s1; amplifying the
coding region for mature BDNF) and Disks large homolog 4
(Dlg4 Mm00492193_m1), gene encoding for PSD-95. Ct values
were normalized to measures of Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH Mm99999915_g1) mRNA. All data
were run in triplicate and analyzed using the 11C(t) method
(Schmittgen and Livak, 2008). Results are expressed as fold
changes relative to the correspondent vehicle-treated group.
Statistics
Time spent (s) in each of the three chambers was used as a
dependent measure. Data were analyzed by repeated-measures
ANOVA with one between factor (treatment, two levels: vehicle,
prazosin) and one within factor (choice, three levels: center,
paired, and unpaired). Post hoc comparisons were assessed by
Duncan’s multiple-range test whenever significant main effects
were attained. A significant CPP was indicated by a significant
difference between time spent in paired versus unpaired chamber.
BDNF and PSD-95 mRNA levels of expression were compared
between prazosin and vehicle group by paired t-test with
significant values attributed when p< 0.05.
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FIGURE 3 | Effects of pre-trial infusion of prazosin in prelimbic (PL) prefrontal
cortex on expression and extinction of an acquired conditioned place
preference (CPP) induced by systemic injection of 2.5 mg/Kg of
amphetamine. In the x-axis are days. In the y-axis is time spent in center,
paired, and unpaired chamber during pre-test, test, re-test, and non-confined
extinction trials in animals assigned to vehicle (A) and prazosin (B). All data
are expressed as mean (second ± SE) time spent in center, paired, and
unpaired chambers. ∗p < 0.05, ∗∗p < 0.01 in time spent in paired in
comparison with unpaired chamber in vehicle and prazosin infused mice.
RESULTS
Prelimbic Prazosin Infusion Fosters
Extinction of Conditioned Place
Preference Induced by Amphetamine
We first investigated the effects of PL α1-ARs antagonist
infusion on expression and extinction of Amph induced
CPP. Two-way ANOVA showed non-significant (ns) effect for
treatment × choice interaction: F(2,36) = 2.668, ns and for
choice: F(2,36)= 1.932, ns.
Following conditioning (test) and in the trial after surgery (re-
test), all mice expressed a preference for the previously Amph-
paired chamber (Figures 3A,B). Two-way ANOVA revealed
a significant effect for factor choice: [test, F(2,36) = 20.865,
p < 0.01; re-test, F(2,36) = 80.789, p < 0.01]. Duncan’s post hoc
analysis showed that both vehicle and prazosin animals spent
more time in the Amph-paired chamber during test and re-test
(p< 0.01) (Figures 3A,B).
Bilateral infusion of both prazosin and vehicle performed
20 min before the third CPP trial (infusion, Figure 1) did
not affect the expression of Amph CPP (Figures 3A,B). Two-
way ANOVA showed a significant effect for choice: [infusion,
F(2,36) = 26.705; p < 0.01] and post hoc analysis confirmed that
both groups spent more time in Amph-paired chamber during
this trial (prazosin p< 0.01; vehicle p< 0.05) (Figures 3A,B). On
extinction trial 5, mice infused with prazosin reached extinction
criterion of two consecutive days showing non-significant
preference for the drug-paired chamber (Figure 3B), whereas
vehicle treated reached extinction on trial 14 (Figure 3A).
On extinction trials 4 and 5, respectively, statistical analyses
revealed a significant effect of choice [F(2,36) = 62.186;
p < 0.01] and [F(2,36) = 54.946; p < 0.01]. Post hoc test
showed that on both days only vehicle spent more time in
the Amph- than in the saline-paired chamber (p < 0.01)
(Figure 3A).
Recently, it has been shown that PL prazosin infusion can
impair fear memory re-consolidation leading to attenuation of
fear responses (Do-Monte et al., 2013). To evaluate a potential
re-consolidation effect in our results we performed a second
experiment in which prazosin was administrated in PL cortex
5 min after CPP trial (see Figure 1).
As in the previous experiment, during pre-test mice randomly
assigned to vehicle post trial (n = 7) or prazosin post trial
(n = 7) groups did not show preference for the lateral chambers.
Two-way ANOVA revealed non-significant effect for interaction
group × choice: F(2,24) = 0.10, ns and for factor choice:
F(2,24)= 12.994, ns.
In both CPP test and re-test all mice showed the preference for
Amph paired chamber. Two-way ANOVA showed a significant
effect for factor choice: [test, F(2,24) = 55.705; p < 0.01; re-test,
F(2,24) = 54.955; p < 0.01]. The day after post-trial infusion,
extinction (ext) 1, both groups vehicle and prazosin showed
CPP for Amph paired chamber. Two-way ANOVA showed a
significant effect for factor choice during ext 1: F(2,24) = 47.082;
p < 0.01, but non-significant interaction treatment × choice:
F(2,24) = 0.06, ns (Figures 4A,B). Prazosin post-trial group
reached extinction criterion on the fourteenth trial. Statistical
analyses revealed significant effect of choice for both ext 13
[F(2,24) = 41.957; p < 0.01] and ext 14 [F(2,24) = 29.457;
p < 0.01]. However, Duncan’s test showed that in both days
prazosin treated mice did not show difference in time spent in
Amph- in comparison with saline-paired chamber (Figure 4B).
Likewise, vehicle post-trial group reached the extinction criterion
on the 15th trial. Two-way ANOVA revealed significant effect
of the factor choice in both ext 14 [F(2,24) = 29.457; p < 0.01]
and ext 15 [F(2,24) = 23,642; p < 0.01]. Duncan’s test showed
that in both days vehicle post-trial mice have spent an equal
amount of time in the chambers paired with Amph and saline
(Figure 4A).
Finally, we verified whether PL prazosin infusion produced
a facilitator effect on the extinction of Amph-induced CPP
independently by the exposure to the CPP trial context.
In this experiment prazosin or vehicle were administrated
5–6 h before the CPP trial (non-contingent groups). During
pre-test mice randomly assigned to non-contingent vehicle
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FIGURE 4 | Effects of post-trial infusion of prazosin in prelimbic (PL) prefrontal
cortex on expression and extinction of an acquired conditioned place
preference (CPP) induced by systemic injection of 2.5 mg/Kg of
amphetamine. In the x-axis are days. In the y-axis is time spent in center,
paired, and unpaired chamber during pre-test, test, re-test, and non-confined
extinction trials in animals assigned to vehicle (A) and prazosin (B). All data
are expressed as mean (second ± SE) time spent in center, paired, and
unpaired chambers. ∗p < 0.05, ∗∗p < 0.01 in time spent in paired in
comparison with unpaired chamber in vehicle and prazosin infused mice.
(n = 8) or prazosin (n = 10) groups did not show
preference for the lateral chambers (Figures 5A,B). Two-way
ANOVA revealed non-significant effect for treatment × choice
interaction: F(2,32) = 0.423, ns. The factor choice was
significant: F(2,32) = 11.332, p < 0.01. Duncan’s post hoc
test confirmed that both groups spent a greater amount of
time in two lateral chambers in comparison with the central
alley.
During CPP test and re-test all mice showed the preference for
Amph paired chamber. Two-way ANOVA showed a significant
effect for factor choice: [test, F(2,32) = 40.386, p < 0.01; re-test,
F(2,32)= 42.204, p< 0.01]. In the CPP trial after non-contingent
infusion both groups showed a preference for the Amph-paired
chamber (Figures 5A,B). ANOVA revealed no significant effect
for treatment × choice interaction: F = (2,32) = 0.850, ns; but
a significant effect for the factor choice: F = (2,32) = 41,252,
p < 0.01. Non-contingently prazosin infused mice reached the
extinction criterion on trial 8. ANOVA revealed a significant
effect for the factor choice in both ext 7 [F = (2,32) = 47,797,
p < 0.01] and 8 [F = (2,32) = 50,338, p < 0.01]. However,
Duncan’s test showed that in both days only non-contingent
vehicle mice spent more time in the chamber previously paired
with (p < 0.01) (Figure 5A). Note, that non-contingent prazosin
mice showed a spontaneous recovery for Amph CPP during
extinction trial 13 (Figure 5B). Non-contingent vehicle group
reached the criterion of two consecutive daily lack of preference
on the 15th trial. Two-way ANOVA showed a significant effect of
the factor choice in both ext (ext 14 [F(2,32) = 34.749, p < 0.01]
and 15 [F(2,32) = 25,623, p < 0.01]. Duncan’s test showed
that in both days vehicle non-contingent mice spent an equal
amount of time in the chambers paired with Amph and vehicle
(Figure 5A).
Prelimbic Prazosin Infusion, Immediately
before the Exposure to the CPP Trial,
Increases BDNF and PSD-95 mRNA
Expression in the Nucleus Accumbens
Given the delayed effect of the intra-PL prazosin infusion on
the extinction of Amph-induced CPP, we hypothesized that the
acute blockade of PL α1-ARs contingent with the exposure to
the CPP trial context may induce neuroplastic adaptations in
the prefrontal-accumbal network, that underlie the facilitation
of extinction. We thus analyzed by quantitative real-time PCR
the transcription levels of the neurotrophin BDNF and of the
synaptic scaffold PSD-95 as markers of neuroplasticity and
synaptic maturation, respectively. Gene expression was measured
in punches of IL and PL cortices, and NAc core and shell
subregions, of pre-trial prazosin- and vehicle-treated mice. To
ensure that both vehicle and prazosin group were equally exposed
to extinction trials, mice were sacrificed for mRNA assessment
once the preference for Amph CS was extinguished only in
prazosin-treated mice, but not necessarily in the vehicle.
For BDNF analysis, paired t-test revealed a significant increase
of the BDNF transcript in NAc core punches of pre-trial
PL prazosin-infused mice compared to vehicle [t(4) = 3.877,
p < 0.05]. Non-significant effect was observed in NAc shell
[t(4) = 0.888, ns], PL [t(3) = −0.643, ns] or IL [t(4) = −0,697,
ns] (Figure 6). Similarly, the PSD-95 mRNA expression level
increased significantly in NAc shell punches of pre-trial PL
prazosin-infused mice compared to vehicle [t(4) = 2.801,
p < 0.05], while no effect of the drug was observed in NAc core
[t(3)= 2.315, ns], PL [t(3)=−0.197, ns)] or IL [t(4)= 0.049, ns]
(Figure 7). Note that a trend toward an increase was evident in
NAc core.
To test the possibility that the PL prazosin infusion would
induce the observed transcriptional modulation independently of
the contingent exposure to the CPP trial context, we measured
mRNA levels of BDNF and PSD-95 in non-contingently infused
prazosin or vehicle mice again when the compartment-preference
was extinguished. For BDNF analysis, paired t-test revealed a
significant decrease in the BDNF transcript in NAc shell punches
of non-contingently PL-infused prazosin mice compared to
vehicle [t(6) = 2.518, p < 0.05). No differences were observed
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FIGURE 5 | Effects of non-contingent infusion of prazosin in prelimbic (PL) prefrontal cortex on expression and extinction of an acquired conditioned place preference
(CPP) induced by systemic injection of 2.5 mg/Kg of amphetamine. In the x-axis are days. In the y-axis is time spent in center, paired, and unpaired chamber during
pre-test, test, re-test, and non-confined extinction trials in animals assigned to vehicle (A) and prazosin (B). All data are expressed as mean (second ± SE) time spent
in center, paired, and unpaired chambers. ∗p < 0.05, ∗∗p < 0.01 in time spent in paired in comparison with unpaired chamber in vehicle and prazosin infused mice.
in NAc core [t(5) = 1.366, ns], PL [t(2) = 0.991, ns], and IL
[t(2) = −0.087, ns] (Figure 8). Non-significant effect of the
drug was revealed for the PSD-95, in either structure: NAc shell
[t(6)= 0.661, ns], NAc core [t(5)=−1.013, ns], PL [t(2)= 1.034,
ns], and IL [t(1)=−0.332, ns] (Figure 9).
DISCUSSION
This study was aimed at evaluating the role of PL α1-ARs in
the maintenance of CPP to Amph. To this aim we assessed the
effects of a single pre-reactivation infusion of prazosin in the
PL of C57BL/6J mice on the expression of a previously acquired
Amph-induced CPP the day of infusion and the following days,
when mice were tested drug free. Intra-PL prazosin did not
affect expression of Amph-induced CPP the day of infusion,
while in subsequent days it produced a clear-cut advance of
extinction in comparison with vehicle treated animals. Indeed,
from day 5 onward prazosin-treated mice, exposed to the
apparatus, showed no preference for the drug-paired chamber
differently from vehicle group that extinguished preference for
the paired chamber on day 14. Note that this effect of intra-PL
prazosin priming is dependent on its infusion before reactivation,
since if infused far before or after reactivation it did not affect
significantly preference compared with vehicle groups.
A beta-adrenergic receptor antagonist, infused in this area
before CPP test, has been reported to block the expression of
cocaine-seeking the day of infusion and on the following day
when animals are drug-free (Otis et al., 2013). However, in
the present study a possible retrieval effect or general memory
impairment can be ruled out. Indeed, before the onset of
extinction procedure animals assigned to both vehicle and
prazosin treatment were able to retrieve drug-associated memory
in CPP expressing Amph preference for the paired chamber.
We observed here that no extinction occurred the day of
infusion when preference for paired chamber was similar to that
shown by vehicle group while preference in treated mice was no
more evident after subsequent daily testing sessions. Therefore,
a mechanism that could account for not immediately extinction
occurring following infusion should have been searched in
possible neuroplasticity events triggered by intra-PL prazosin.
These could have tagged CS during CPP retrieval, possibly
devaluating it or blunting its association with US to produce a
process that led to “extinction” of preference later on.
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FIGURE 6 | Brain-derived neurotrophic factor (BDNF) mRNA expression in
punches of infralimbic (IL) and prelimbic (PL) cortices, and Nucleus
Accumbens (NAc) core and shell subregions, measured after the extinction of
amphetamine-induced conditioned place preference (CPP), in mice that
received pre-trial infusion of prazosin or vehicle in PL. The BDNF mRNA
expression level (relative expression levels = fold changes over vehicle,
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene)
was significantly increased in the NAc core of Prazosin versus Vehicle-infused
mice. ∗p < 0.05.
FIGURE 7 | Postsynaptic density protein 95 (PSD-95) mRNA expression in
punches of IL and PL cortices, and NAc core and shell subregions, measured
after the extinction of amphetamine-induced CPP, in mice that received
pre-trial infusion of prazosin or vehicle in PL. The PSD-95 mRNA expression
level (relative expression levels = fold changes over vehicle, normalized to
GAPDH gene) was significantly increased in the NAc shell of Prazosin versus
Vehicle-infused mice. ∗p < 0.05.
Such neuroplasticity events could have involved not only the
brain areas where the antagonist was infused but also other areas
that are known to be connected with it and playing a functional
role in expression, reconsolidation or extinction of association
between CS and drugs.
Lasting efficacy of prazosin in the short period could not
be ruled out (Blanc et al., 1994); however, if the compound
were effective in testing sessions following intra PL infusion,
behavioral effects (extinction) should have been evident also in
mice treated non-contingently with exposure to the apparatus.
Moreover, post-retrieval treatment did not affect place preference
significantly, thus ruling out a possible interference with
consolidation of reconsolidation (Dudai and Eisenberg, 2004)
produced by intra-PL prazosin prior reactivation due to long-
lasting pharmacological action.
To evaluate neuroplastic adaptations we chose to analyze the
transcriptional modulation of BDNF and PSD-95 genes. BDNF
is a neurotrophin that is critically involved in the activity-
dependent regulation of synaptic structure and function and
thus it is considered a reliable marker of neuronal plasticity.
BDNF is released upon neuronal activation and exerts its
effect on synaptic strength, modulation of dendritic growth,
changes in spine density and morphology, by stimulation of
protein synthesis and transcription activity, which account for
its delayed effect (Carvalho et al., 2008). Interestingly BDNF-
induced neuroplasticity has been shown to induce extinction
(Rosas-Vidal et al., 2014).
PSD-95 is the most abundant scaffolding protein at mature
glutamate synapses and is essential for synaptic maturation and
plasticity (El-Husseini et al., 2000). BDNF signaling is known to
promote PSD-95 translation and trigger transport of PSD-95 to
the synapse where it contributes to the structural and functional
maturation of synapses (Yoshii et al., 2011).
In our experiment we assessed transcriptional expression
of BDNF and PSD-95 in mice that had extinguished CPP.
Specifically, we evaluated mRNA levels in PL and IL cortices and
NAc subdivision shell and core (areas of a prefrontal-accumbal
network modulating incentive salience and extinction).
The results showed that prazosin-treated mice having
extinguished preference showed an increase in BDNF mRNA
expression in NAc core, and an increase of PSD-95 in NAc
shell, in comparison with vehicle, while non-significant effects
on expression of BDNF or PSD95 were evident in PL and IL, or
in all punches of animals that were infused with the antagonist
non-contingently with reactivation, but in NAc shell where lower
BDNF levels were evident.
Overall these results indicate the NAc core and shell as
key target structures involved in the neuroplastic adaptations
mounted by PL cortex upon prazosin infusion and associated
with the facilitation of extinction. Interestingly, we found that in
NAc core the significative increase in BDNF mRNA levels was
associated to similar trend in PSD-95 accordingly to previous
reports (Li et al., 2013). This data could be interpreted in
light of the different role of the two molecules in neuroplastic
mechanisms. While BDNF indicates an ongoing neurotrophic
activity in neurons, PSD-95 indicates the morphological result of
neuroplasticity, consequence of BDNF activity and thus delayed
in time. The transcriptional modulation observed demonstrates
an active dynamics of neuroplasticity mechanisms induced by
PL-infused prazosin in NAc, despite the detection of mRNA
rather then protein, allows us only to speculate on the functional
direction of the differences observed.
These results, that can not rule out other different neural
plasticity effects in cortical functioning in our experimental
conditions, indicate that PL (target area of prazosin priming)
is likely to drive functional process in subcortical areas that
result in neuroplasticity changes strongly related to extinction of
Amph-induced CPP.
Indeed, BDNF and PSD95 expression increase was evident
only in animals that had extinguished, but not in vehicle matched
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FIGURE 8 | Brain-derived neurotrophic factor (BDNF) mRNA expression in
punches of IL and PL cortices, and NAc core and shell subregions, measured
after the extinction of amphetamine-induced CPP, in mice that received
non-contingent infusion of prazosin or vehicle in PL. The BDNF mRNA
expression level (relative expression levels = fold changes over vehicle,
normalized to GAPDH gene) was significantly decreased in the NAc shell of
Prazosin versus Vehicle-infused mice. ∗p < 0.05.
FIGURE 9 | Postsynaptic density protein 95 (PSD-95) mRNA expression in
punches of IL and PL cortices, and NAc core and shell subregions, measured
after the extinction of amphetamine-induced CPP, in mice that received
non-contingent infusion of Prazosin or Vehicle in PL. Non-significant
differences were observed in PSD-95 mRNA expression level (relative
expression levels = fold changes over vehicle, normalized to GAPDH gene) in
either structure.
group or in mice that received prazosin out of the retrieval
session, namely non-contingently with exposure with the CPP
apparatus and that not extinguished yet preference for Amph
paired CS. It worth noting also that these effects were exposure-
dependent, a relevant result in the perspective of possible drug
assisted behavioral therapy pointed out by our preclinical model.
Moreover behavioral and molecular results are relevant since
they point out a possible “priming” effect of the antagonist that
suggests a potential therapeutic power (to be further ascertained),
given by efficacy of single or sporadic pharmacological (prazosin)
treatment with the huge advantage of limiting possible side effects
of a repeated treatment.
Note that α1-AR stimulation was reported to induce
neuroplasticity (Sawaki et al., 2003; Neverova et al., 2007;
McElligott et al., 2010), therefore antagonists should be possibly
able to impair neuroplasticity processes induced by receptor
activation but is questionable that antagonists themselves
produce neuroplastic effects through receptor blockade per se.
A body of research of R.S. Duman and his associates has
addressed authoritatively the mechanisms of neural plasticity
induced by receptor antagonists. They have demonstrated that
two antagonists of NMDA or muscarinic receptor, ketamine
and scopolamine respectively, provided of clear antidepressant
properties, after acute intra-cortical infusion produce increased
glutamate transmission that is able to trigger neuroplasticity
mechanisms leading to long-lasting behavioral and synaptic
changes, also through BDNF. The action of acute (single)
administration is transient, and its effects on glutamate depend
on blockade of GABA interneurons tonic firing (Duman and
Aghajanian, 2012, 2014; Wohleb et al., 2017). Moreover, it has
been recently reported that acute ketamine infused in mPFC
modulate extinction of conditioned fear (Girgenti et al., 2017).
In these studies neuroplasticity effects occur in cortical
areas where drugs are infused, while our present results
show neuroplasticity occurring in NAc, although other neural
plasticity mechanisms not assessed here cannot be ruled-out.
These effects on NAc are consistent with a role of mesolimbic
system in modulation of salient stimuli and motivated behavior
characterizing CPP to a psychostimulant such that used in
our experiments. However, neural plasticity events are likely to
originate in the prefrontal cortex and need the animal to be
exposed to CS, as is clearly indicated by the results of prazosin
infusion non-contingently to the extinction process.
Similarly to what shown for ketamine and scopolamine,
we hypothesize that prazosin triggers mechanisms that
involves different neurotransmitters. This view is supported
by unpublished results obtained in reverse microdialysis
experiments showing that prazosin, in CPP extinction procedure,
increases dopamine outflow while decreases GABA levels in PL.
These effects could spur molecular events, possibly involving
glutamate, to promote neural and behavioral plasticity. It is
worth noting to mind that a possible increase of prefrontal
cortical dopamine by prazosin was hypothesized by Blanc and
coworkers a couple of decades ago (Blanc et al., 1994).
Thus it is conceivable that prazosin, possibly altering neural
events involving different neurotransmitters in close neurons in
PL or in distal neuron of areas connected with PL (e.g., NAc),
directly or through trans-neuronal feedback, is able to trigger
neuroplastic adaptations such those we observed here. Further
study could possibly elucidate this point.
Present results can involve the action of different factors.
NE transmission in prefrontal cortex is pivotal in acquisition
of motivational properties of different classes of rewarding and
aversive stimuli that spur NE release in this area (Ventura et al.,
2005, 2007, 2008). Moreover, exposure to appetitive CS can
induce prefrontal NE release and the magnitude of this release
is positively related to the salience of the US during the training
session (Mingote et al., 2004; Ventura et al., 2008). Note that
increased prefrontal NE release leads to increase of DA release
in the NAc and the paired prefrontal-accumbal catecholamine
are crucial in attribution of motivational salience involving highly
salient USs (Darracq et al., 1998; Ventura et al., 2003, 2005, 2007).
Frontiers in Pharmacology | www.frontiersin.org 9 August 2017 | Volume 8 | Article 530
fphar-08-00530 August 8, 2017 Time: 15:41 # 10
Latagliata et al. Prelimbic Prazosin Infusion Fosters Extinction
Therefore, we hypothesize that repeated exposure to the
environment paired with Amph was able to increase NE
levels in mPFC in control (vehicle) animals, and that this
increase contributed to maintain the motivational properties
of CS fostering drug-seeking behavior. Conversely, acute intra-
PL prazosin blocked the effects of NE release on α1-ARs
in animals exposed to Amph conditioned environment. This
resulted in blunting the motivational properties of CS and
reducing the persistence of CPP in following days, supported by
neuroplasticity processes as those observed in the NAc. Moreover,
it is well known that repeated non-reinforced exposure to the
CS reduces the CR leading to its extinction (Pavlov, 1927;
Berman et al., 2003). Accordingly, extinction is conceptualized
as a new context-dependent learning that competes with the
original learning to control motivation and behavior (Bouton,
2004; McNally, 2014). Therefore, during extinction trials,
the original association (Amph-CS) could have undergone a
substantial reduction of salience under prazosin action, due to the
antagonist-induced impairment of prelimbic NE transmission
following exposure to the CS.
Our results point to neuroplasticity effects in NAc, suggesting
a prefrontal-accumbal modulation of CS related motivational
salience. These effects may be due to prazosin blockade of
activation of postsynaptic Gq-coupled α1-ARs and PKC that
have been shown to inhibit persistent activity of prefrontal
pyramidal neurons (Birnbaum et al., 2004), Therefore, it can
be hypothesized that prazosin in PL increases the activity of
pyramidal neurons in this area counteracting the hypoactivity
of mPFC possibly induced by both Amph administration and
conditioned NE release and thus sustaining the inhibitory
control over drug-seeking, a view that needs further study to be
ascertained.
In addition to this, a possible interplay between PL and IL
should be taken into account. Indeed, we have recently shown
that NE transmission modulates extinction of Amph-induced
CPP through a balance between PL and IL (Latagliata et al., 2016).
Therefore, exposure to Amph-paired environment in intra-PL
prazosin animals could have shifted the weight of NE in favor of
the IL, thus fostering the emergence of extinction trace that would
prevail in modulating behavioral outcome. Further experiments
could elucidate this point. However, it is worth noting that
we observed here changes in BDNF and PSD-95 expression in
both accumbal subregions core and shell that are well known
to be involved in motivation and in extinction also due to their
connections with PL and IL (Bouton, 2004; Miller and Marshall,
2004; Kalivas et al., 2005; Peters et al., 2009; Martín-García et al.,
2014; McNally, 2014). Thus, it may be that prefrontal driven
modulation of NAc core and shell, resulting in BDNF and PSD-
95 expression, promote extinction of US-CS association and/or
blunt motivational salience of CS respectively.
Our present results leave a number of points open. Additional
specific molecular mechanisms involved in neuroplasticity could
be further investigated, to ascertain the effects of acute prazosin in
short- and in long-term plasticity in PL. The involvement of other
neurotransmitter action, such as dopamine, GABA, glutamate on
plasticity and behavior must be assessed. Unveiling the role of
different neurotransmitters can help to envisage possible acute
therapy based on combined treatment with compounds acting
synergistically on different neural mechanisms to spur synaptic
and learning processes, possibly at low dosage to minimize side
effects. The effects of acute systemic antagonist administration on
brain and behavior are to be elucidated and compared with those
of intra-cerebral infusion, to assess its therapeutic power.
CONCLUSION
A single pre-reactivation infusion of prazosin in the PL of
C57BL/6J mice did not affect expression of Amph-induced CPP
the day of infusion, while in subsequent days it produced a clear-
cut advance of extinction, an effect depending on contingent
exposure to retrieval, since if infused far from or after reactivation
it did not affect preference.
BDNF and PSD-95 expression increase in the NAc Core and
Shell, that are part of a prefrontal-accumbal network modulating
incentive salience and extinction, was evident only in animals
that had extinguished, but not in vehicle matched group or in
mice that had received prazosin out of the retrieval session.
These neuroplasticity events triggered by intra-PL prazosin could
have tagged CS during CPP retrieval, possibly devaluating it or
blunting its association with US, point to a mechanism that could
account for non-immediately expressed extinction.
Both behavioral and molecular results are relevant since they
point, for the first time to our knowledge, to a possible “priming”
effect of prazosin that suggests a potential therapeutic power
(to be further ascertained) of the antagonist for maladaptive
memories, resulting by the efficacy of a single or sporadic
pharmacological treatment allowing to avoid possible side effects
of repeated drug treatment.
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